Cargando…

Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes

Exosomes are a distinct population of extracellular vesicles of endocytic origin with a protein repertoire similar to the parent cell. Although tumour-derived exosomes harbour immunosuppressive characteristics, they also carry tumour antigens and thus potentially contribute to immune activation. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Salimu, Josephine, Webber, Jason, Gurney, Mark, Al-Taei, Saly, Clayton, Aled, Tabi, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613918/
https://www.ncbi.nlm.nih.gov/pubmed/28959385
http://dx.doi.org/10.1080/20013078.2017.1368823
_version_ 1783266339372138496
author Salimu, Josephine
Webber, Jason
Gurney, Mark
Al-Taei, Saly
Clayton, Aled
Tabi, Zsuzsanna
author_facet Salimu, Josephine
Webber, Jason
Gurney, Mark
Al-Taei, Saly
Clayton, Aled
Tabi, Zsuzsanna
author_sort Salimu, Josephine
collection PubMed
description Exosomes are a distinct population of extracellular vesicles of endocytic origin with a protein repertoire similar to the parent cell. Although tumour-derived exosomes harbour immunosuppressive characteristics, they also carry tumour antigens and thus potentially contribute to immune activation. The aim of this study was to examine the impact of prostate cancer exosomes on tumour antigen cross-presentation. DU145 cells, transduced with shRNA to knockdown Rab27a (DU145(KD)) that inhibits exosome secretion, triggered significantly stronger tumour-antigen-specific T cell responses when loaded onto dendritic cells (DC) than control DU145 cells. Enhanced T cell response was prevented by adding purified exogenous DU145 exosomes to DU145(KD) cells, demonstrating that the dominant effect of tumour exosomes is immunosuppression and not antigen delivery. CD8(+) T cell responses were impaired via exosomal regulation of DC function; exosomes triggered the expression of CD73, an ecto-5-nucleotidase responsible for AMP to adenosine hydrolysis, on DC. CD73 induction on DC that constitutively express CD39 resulted in an ATP-dependent inhibition of TNFα- and IL-12-production. We identified exosomal prostaglandin E(2) (PGE(2)) as a potential driver of CD73 induction, as inhibition of PGE(2) receptors significantly reduced exosome-dependent CD73 induction. The results reveal a hitherto unknown suppression of DC function via exosomal PGE(2), adding a new element to tumour exosome–immune cell cross-talk. Abbreviations: AMP: adenosine monophosphate; ATP: adenosine triphosphate; BLCL: B lymphoblastoid cell line; CME: exosomes enriched from cell line conditioned media; DC: dendritic cell; DMSO: dimethyl-sulfoxide; DU145(C): DU145 cells with irrelevant knockdown control; DU145(KD): DU145 cells with Rab27a knockdown; ELISA: enzyme-linked immunosorbent assay; FBS: fetal bovine serum; GM-CSF: granulocyte-monocyte colony stimulating factor; HLA: human lymphocyte antigen; IL: interleukin; LPS: lipopolysaccharide; mfi: mean fluorescence intensity; PBMC: peripheral blood mononuclear cells; PBS: phosphate buffer solution; PGE(2): prostaglandin E(2); TRF: time-resolved fluorescence.
format Online
Article
Text
id pubmed-5613918
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-56139182017-09-28 Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes Salimu, Josephine Webber, Jason Gurney, Mark Al-Taei, Saly Clayton, Aled Tabi, Zsuzsanna J Extracell Vesicles Original Research Article Exosomes are a distinct population of extracellular vesicles of endocytic origin with a protein repertoire similar to the parent cell. Although tumour-derived exosomes harbour immunosuppressive characteristics, they also carry tumour antigens and thus potentially contribute to immune activation. The aim of this study was to examine the impact of prostate cancer exosomes on tumour antigen cross-presentation. DU145 cells, transduced with shRNA to knockdown Rab27a (DU145(KD)) that inhibits exosome secretion, triggered significantly stronger tumour-antigen-specific T cell responses when loaded onto dendritic cells (DC) than control DU145 cells. Enhanced T cell response was prevented by adding purified exogenous DU145 exosomes to DU145(KD) cells, demonstrating that the dominant effect of tumour exosomes is immunosuppression and not antigen delivery. CD8(+) T cell responses were impaired via exosomal regulation of DC function; exosomes triggered the expression of CD73, an ecto-5-nucleotidase responsible for AMP to adenosine hydrolysis, on DC. CD73 induction on DC that constitutively express CD39 resulted in an ATP-dependent inhibition of TNFα- and IL-12-production. We identified exosomal prostaglandin E(2) (PGE(2)) as a potential driver of CD73 induction, as inhibition of PGE(2) receptors significantly reduced exosome-dependent CD73 induction. The results reveal a hitherto unknown suppression of DC function via exosomal PGE(2), adding a new element to tumour exosome–immune cell cross-talk. Abbreviations: AMP: adenosine monophosphate; ATP: adenosine triphosphate; BLCL: B lymphoblastoid cell line; CME: exosomes enriched from cell line conditioned media; DC: dendritic cell; DMSO: dimethyl-sulfoxide; DU145(C): DU145 cells with irrelevant knockdown control; DU145(KD): DU145 cells with Rab27a knockdown; ELISA: enzyme-linked immunosorbent assay; FBS: fetal bovine serum; GM-CSF: granulocyte-monocyte colony stimulating factor; HLA: human lymphocyte antigen; IL: interleukin; LPS: lipopolysaccharide; mfi: mean fluorescence intensity; PBMC: peripheral blood mononuclear cells; PBS: phosphate buffer solution; PGE(2): prostaglandin E(2); TRF: time-resolved fluorescence. Taylor & Francis 2017-09-03 /pmc/articles/PMC5613918/ /pubmed/28959385 http://dx.doi.org/10.1080/20013078.2017.1368823 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Salimu, Josephine
Webber, Jason
Gurney, Mark
Al-Taei, Saly
Clayton, Aled
Tabi, Zsuzsanna
Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
title Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
title_full Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
title_fullStr Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
title_full_unstemmed Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
title_short Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
title_sort dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613918/
https://www.ncbi.nlm.nih.gov/pubmed/28959385
http://dx.doi.org/10.1080/20013078.2017.1368823
work_keys_str_mv AT salimujosephine dominantimmunosuppressionofdendriticcellfunctionbyprostatecancerderivedexosomes
AT webberjason dominantimmunosuppressionofdendriticcellfunctionbyprostatecancerderivedexosomes
AT gurneymark dominantimmunosuppressionofdendriticcellfunctionbyprostatecancerderivedexosomes
AT altaeisaly dominantimmunosuppressionofdendriticcellfunctionbyprostatecancerderivedexosomes
AT claytonaled dominantimmunosuppressionofdendriticcellfunctionbyprostatecancerderivedexosomes
AT tabizsuzsanna dominantimmunosuppressionofdendriticcellfunctionbyprostatecancerderivedexosomes